Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Withdrawn × Cytoreductive Surgery × Clear all

Phase

Status

Withdrawn 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 115 Neoplasms 69 Prostatic Neoplasms 61 Lung Neoplasms 30 Carcinoma, Non-Small-Cell Lung 30 Pancreatic Neoplasms 28 Head and Neck Neoplasms 28 Colorectal Neoplasms 28 Brain Neoplasms 22 Carcinoma, Hepatocellular 21 Colonic Neoplasms 20 Motor Activity 19 Pain 15 Carcinoma, Renal Cell 14 Rectal Neoplasms 13 Ovarian Neoplasms 13 Fatigue 13 Urinary Bladder Neoplasms 12 Neoplasm Metastasis 12 Liver Neoplasms 11 Hematologic Neoplasms 11 Sarcoma 10 Lymphoma, Follicular 10 Glioblastoma 10 Anxiety Disorders 10 Stomach Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma 9 Leukemia 9

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05390021 2024-04-02

PET/MRI in Endometrial Cancer

Massachusetts General Hospital

Phase NA Withdrawn

Cytoreductive Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡